Protective effect of berberine on renal fibrosis caused by diabetic nephropathy
Authors:
Open Access
- 1 February 2017
- journal article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 16 (2) , 1055-1062
Abstract
Berberine (BBR) is a material extracted from Chinese herbs, which has been used in the treatment of diabetes in Chinese medicine for thousands of years. However, the importance of BBR in renal fibrosis remains to be elucidated. In the present study, streptozotocin‑induced diabetic nephropathy (DN) rats were used to determine the effect of BBR on renal fibrosis. The pathology of the kidneys was examined using periodic acid‑Schiff (PAS) and Masson staining. The expression levels of transforming growth factor‑β (TGF‑β) and α smooth muscle actin (α‑SMA) in kidneys were observed using immunohistochemical staining. The mRNA and protein expression levels of TGF‑β, α‑SMA, vimentin, nuclear factor‑κB were examined using reverse transcription‑quantitative polymerase chain reaction and western blotting, respectively. PAS and Masson staining revealed that there was notable glomerular hypertrophy and mesangial matrix expansion in DN rats. Immunohistochemistry revealed that there was a significant increase in TGF‑β and α‑SMA expression levels in the renal tubulointerstitium and the extracellular matrix. However, treatment with BBR may significantly reduce kidney injury. The protein and mRNA expression levels of TGF‑β, vimentin and α‑SMA were significantly increased in DN rats compared with the control group; however, this increase was reduced following treatment with BBR. The present study revealed that BBR may inhibit fibrosis and ameliorate the symptoms of DN. The current findings indicated that BBR may be used as a potential treatment for patients with DN.Keywords
This publication has 28 references indexed in Scilit:
- Berberine and its derivatives: a patent review (2009 – 2012)Expert Opinion on Therapeutic Patents, 2012
- Dioscorea alata Attenuates Renal Interstitial Cellular Fibrosis by Regulating Smad- and Epithelial-Mesenchymal Transition Signaling PathwaysPLOS ONE, 2012
- Treating diabetic nephropathy—still an unresolved issueNature Reviews Endocrinology, 2012
- Resveratrol ameliorates early diabetic nephropathy associated with suppression of augmented TGF-β/smad and ERK1/2 signaling in streptozotocin-induced diabetic ratsChemico-Biological Interactions, 2011
- Attenuation of Diabetic Nephropathy in Otsuka Long‐Evans Tokushima Fatty (OLETF) Rats with a Combination of Chinese Herbs (Tangshen Formula)Evidence-Based Complementary and Alternative Medicine, 2011
- Astragaloside IV synergizes with ferulic acid to inhibit renal tubulointerstitial fibrosis in rats with obstructive nephropathyBritish Journal of Pharmacology, 2011
- Diabetic kidney disease: act now or pay laterKidney International, 2010
- Effect of green tea on kidney tubules of diabetic ratsBritish Journal of Nutrition, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Alpha-Smooth Muscle Actin Expression Upregulates Fibroblast Contractile ActivityMolecular Biology of the Cell, 2001